Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results

An Innovative and Linguistically-Tailored Mobile Intervention to Improve Follow-Up for Abnormal Pap Test Results: CervixChat

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04821297

Enrollment

Registered

2021-03-29

Start date

2021-02-18

Completion date

2021-09-10

Last updated

2025-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Carcinoma

Brief summary

This clinical trial evaluates the feasibility of a linguistically-tailored mobile intervention, called CervixChat in improving the follow-up of patients with abnormal Papanicolaou (pap) test results. A text messaging program, such as CervixChat may support patients who need a colposcopy.

Detailed description

PRIMARY OBJECTIVE: I. To evaluate the feasibility of CervixChat intervention in a mix method design, through participants consent rate and the study completion rate. SECONDARY OBJECTIVE: I. To evaluate the acceptability of CervixChat intervention using a validated Likert-scale participant satisfaction questionnaire, as well as participant's interview data. EXPLORATORY OBJECTIVE: I. To evaluate the preliminary impact of CervixChat intervention, by comparing the colposcopy appointment adherence rate in the study cohort against a 1:1 matched control sample selected based on matching age, race and ethnicity, from participants at Jefferson Obstetrics and Gynecology (Ob-Gyn) department scheduled for a colposcopy in 2019. OUTLINE: Patients receive text messages for 1-2 months before scheduled appointment. Patients also complete a survey at baseline and after standard of care colposcopy and an interview after standard of care colposcopy. After completion of study, patients are followed up periodically.

Interventions

OTHERHealth Promotion and Education

Receive messages

OTHERSurvey Administration

Complete survey

OTHERInterview

Participate in an interview

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

21 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Female, aged 21 to 65 years of age * Had received an abnormal Pap smear result * Scheduled colposcopy * Able to communicate with ease in English or Spanish * Have a cell phone with text (TXT) ability * Competent to give consent

Exclusion criteria

* Are pregnant at the time of recruitment * Display current evidence of positive invasive carcinoma of the cervix

Design outcomes

Primary

Measure	Time frame
Patient Consent Rate	Up to 12 months
Study Completion Rate	Up to 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026